Agbuduwe C, Iqbal G, Cairns D, Menzies T, Dunn J, Gregory W, Kaiser M, Owen R, Pawlyn C, Child JA, Davies F, Morgan GJ, Jackson GH, Drayson MT, Basu S (2022) Clinical characteristics and outcomes of IgD myeloma: experience across UK national trials. Blood Adv 6:5113–5123. https://doi.org/10.1182/bloodadvances.2022007608

Article  PubMed  PubMed Central  CAS  Google Scholar 

Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, Arnold W (1999) Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer 85:2305–2314

Article  PubMed  CAS  Google Scholar 

Basset M, Hummedah K, Kimmich C, Veelken K, Dittrich T, Brandelik S, Kreuter M, Hassel J, Bosch N, Stuhlmann-Laeisz C, Blank N, Muller-Tidow C, Rocken C, Hegenbart U, Schonland S (2020) Localized immunoglobulin light chain amyloidosis: novel insights including prognostic factors for local progression. Am J Hematol 95:1158–69. https://doi.org/10.1002/ajh.25915

Article  PubMed  Google Scholar 

Berentsen S, Barcellini W, D’Sa S, Randen U, Tvedt THA, Fattizzo B, Haukas E, Kell M, Brudevold R, Dahm AEA, Dalgaard J, Froen H, Hallstensen RF, Jaeger PH, Hjorth-Hansen H, Malecka A, Oksman M, Rolke J, Sekhar M, Sorbo JH, Tjonnfjord E, Tsykunova G, Tjonnfjord GE (2020) Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood 136:480–488. https://doi.org/10.1182/blood.2020005674

Article  PubMed  Google Scholar 

Berentsen S, Malecka A, Randen U, Tjonnfjord GE (2020) Cold agglutinin disease: where do we stand, and where are we going? Clin Adv Hematol Oncol 18:35–44

PubMed  Google Scholar 

Bergsagel PL, Kuehl WM (2005) Molecular pathogenesis and a consequent classification of multiple myeloma. J Clin Oncol 23:6333–6338

Article  PubMed  CAS  Google Scholar 

Bink K, Haralambieva E, Kremer M, Ott G, Beham-Schmid C, de Leval L, Peh SC, Laeng HR, Jutting U, Hutzler P, Quintanilla-Martinez L, Fend F (2008) Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Haematologica 93:623–626. https://doi.org/10.3324/haematol.12005

Article  PubMed  Google Scholar 

Boll M, Parkins E, O’Connor SJ, Rawstron AC, Owen RG (2010) Extramedullary plasmacytoma are characterized by a ‘myeloma-like’ immunophenotype and genotype and occult bone marrow involvement. Br J Haematol 151:525–527. https://doi.org/10.1111/j.1365-2141.2010.08386

Article  PubMed  Google Scholar 

Boyle EM, Deshpande S, Tytarenko R, Ashby C, Wang Y, Bauer MA, Johnson SK, Wardell CP, Thanendrarajan S, Zangari M, Facon T, Dumontet C, Barlogie B, Arbini A, Rustad EH, Maura F, Landgren O, Zhan F, van Rhee F, Schinke C, Davies FE, Morgan GJ, Walker BA (2021) The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma. Nat Commun 12:293. https://doi.org/10.1038/s41467-41020-20524-41462

Article  Google Scholar 

Bustoros M, Anand S, Sklavenitis-Pistofidis R, Redd R, Boyle EM, Zhitomirsky B, Dunford AJ, Tai YT, Chavda SJ, Boehner C, Neuse CJ, Rahmat M, Dutta A, Casneuf T, Verona R, Kastritis E, Trippa L, Stewart C, Walker BA, Davies FE, Dimopoulos MA, Bergsagel PL, Yong K, Morgan GJ, Aguet F, Getz G, Ghobrial IM (2022) Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes. Nat Commun 13:3449. https://doi.org/10.1038/s41467-41022-30694-w

Article  Google Scholar 

Bustoros M, Sklavenitis-Pistofidis R, Park J, Redd R, Zhitomirsky B, Dunford AJ, Salem K, Tai YT, Anand S, Mouhieddine TH, Chavda SJ, Boehner C, Elagina L, Neuse CJ, Cha J, Rahmat M, Taylor-Weiner A, Van Allen E, Kumar S, Kastritis E, Leshchiner I, Morgan EA, Laubach J, Casneuf T, Richardson P, Munshi NC, Anderson KC, Trippa L, Aguet F, Stewart C, Dimopoulos MA, Yong K, Bergsagel PL, Manier S, Getz G, Ghobrial IM (2020) Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression. J Clin Oncol 38:2380–2389. https://doi.org/10.1200/JCO.2320.00437

Article  Google Scholar 

Caers J, Paiva B, Zamagni E, Leleu X, Blade J, Kristinsson SY, Touzeau C, Abildgaard N, Terpos E, Heusschen R, Ocio E, Delforge M, Sezer O, Beksac M, Ludwig H, Merlini G, Moreau P, Zweegman S, Engelhardt M, Rosinol L (2018) Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. J Hematol Oncol 11:10. https://doi.org/10.1186/s13045-017-0549-1

Article  PubMed  PubMed Central  CAS  Google Scholar 

Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman A, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles GA, San-Miguel JF, Seymour JF, Treon SP, Vose J, Zucca E, Advani R, Ansell SM, Au WY, Barrionuevo C, Bergsagel PL, Chan WC, Cohen JI, d’Amore F, Davies AJ, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim WS, Kumar SK, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, López-Guillermo A, Mateos MV, Macintyre EA, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris MA, Pro B, Rajkumar SVV, Rosen ST, Sander B, Sehn LH, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani PL, Dreyling M, Scott DW, Winter JN, Zelenetz AD (2022) The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140:1229–1253. https://doi.org/10.1182/blood.2022015851

Article  PubMed  CAS  Google Scholar 

Castillo JJ, Jurczyszyn A, Brozova L, Crusoe E, Czepiel J, Davila J, Dispenzieri A, Eveillard M, Fiala MA, Ghobrial IM, Gozzetti A, Gustine JN, Hajek R, Hungria V, Jarkovsky J, Jayabalan D, Laubach JP, Lewicka B, Maisnar V, Manasanch EE, Moreau P, Morgan EA, Nahi H, Niesvizky R, Paba-Prada C, Pika T, Pour L, Reagan JL, Richardson PG, Shah J, Spicka I, Vij R, Waszczuk-Gajda A, Gertz MA (2017) IgM myeloma: a multicenter retrospective study of 134 patients. Am J Hematol 92:746–751. https://doi.org/10.1002/ajh.24753

Article  PubMed  CAS  Google Scholar 

Castillo JJ, Moreno DF, Arbelaez MI, Hunter ZR, Treon SP (2019) CXCR4 mutations affect presentation and outcomes in patients with Waldenstrom macroglobulinemia: a systematic review. Expert Rev Hematol 12:873–881. https://doi.org/10.1080/17474086.2019.1649132

Article  PubMed  CAS  Google Scholar 

Chng WJ, Huang GF, Chung TH, Ng SB, Gonzalez-Paz N, Troska-Price T, Mulligan G, Chesi M, Bergsagel PL, Fonseca R (2011) Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma. Leukemia 25:1026–1035. https://doi.org/10.1038/leu.2011.53

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dao LN, Hanson CA, Dispenzieri A, Morice WG, Kurtin PJ, Hoyer JD (2011) Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients. Blood 117:6438–6444. https://doi.org/10.1182/blood-2010-11-316935

Article  PubMed  PubMed Central  CAS  Google Scholar 

de Leval L, Alizadeh AA, Bergsagel PL, Campo E, Davies AJ, Dogan A, Fitzgibbon J, Horwitz SM, Melnick AM, Morice WG, Morin RD, Nadel B, Pileri SA, Rosenquist R, Rossi D, Salaverria I, Steidl C, Treon SP, Zelenetz AD, Advani R, Allen CE, Ansell SM, Chan WC, Cook JR, Cook LB, d’Amore F, Dirnhofer S, Dreyling M, Dunleavy K, Feldman A, Fend F, Gaulard P, Ghia P, Gribben JG, Hermine O, Hodson DJ, Hsi ED, Inghirami GG, Jaffe ES, Karube K, Kataoka K, Klapper W, Kim WS, King RL, Ko YH, LaCasce AS, Lenz G, Martin-Subero I, Piris MA, Pittaluga S, Pasqualucci L, Quintanilla-Martinez L, Rodig SJ, Rosenwald A, Salles GA, San-Miguel J, Savage KJ, Sehn LH, Semenzato G, Staudt LM, Swerdlow SH, Tam CS, Trotman J, Vose J, Weigert O, Wilson WH, Winter JN, Wu CJ, Zinzani PL, Zucca E, Bagg A, Scott DWW (2022) Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. https://doi.org/10.1182/blood.2022015854

Article  PubMed  Google Scholar 

Dispenzieri A (2014) POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management. Am J Hematol 89:214–223. https://doi.org/10.1002/ajh.23644

Article  PubMed  Google Scholar 

Dispenzieri A (2021) POEMS syndrome: 2021 update on diagnosis, risk-stratification, and management. Am J Hematol 96:872–888. https://doi.org/10.1002/ajh.26240

Article  Google Scholar 

Drach J, Angerler J, Schuster J, Rothermundt C, Thalhammer R, Haas OA, Jager U, Fiegl M, Geissler K, Ludwig H, Huber H (1995) Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 86:3915–3921

Article  PubMed  CAS  Google Scholar 

Dupuis MM, Tuchman SA (2016) Non-secretory multiple myeloma: from biology to clinical management. Onco Targets Ther 9:7583–7590. https://doi.org/10.2147/OTT.S122241

Article  PubMed  PubMed Central  CAS  Google Scholar 

Falini B, Agostinelli C, Bigerna B, Pucciarini A, Pacini R, Tabarrini A, Falcinelli F, Piccioli M, Paulli M, Gambacorta M, Ponzoni M, Tiacci E, Ascani S, Martelli MP, Dalla Favera R, Stein H, Pileri SA (2012) IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. Histopathology 61:930–941. https://doi.org/10.1111/j.1365-2559.2012.04289.x

Article  PubMed  Google Scholar 

Fermand JP, Bridoux F, Dispenzieri A, Jaccard A, Kyle RA, Leung N, Merlini G (2018) Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications. Blood 132:1478–1485. https://doi.org/10.1182/blood-2018-1404-839480

Article  Google Scholar 

Fernandez de Larrea C, Kyle R, Rosinol L, Paiva B, Engelhardt M, Usmani S, Caers J, Gonsalves W, Schjesvold F, Merlini G, Lentzch S, Ocio E, Garderet L, Moreau P, Sonneveld P, Badros A, Gahrton G, Goldschmidt H, Tuchman S, Einsele H, Durie B, Wirk B, Musto P, Hayden P, Kaiser M, Miguel JS, Blade J, Rajkumar SV, Mateos MV (2021) Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood Cancer J 11:192. https://doi.org/10.1038/s41408-021-00587-0

Article  PubMed  PubMed Central  Google Scholar 

Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD Jr, Stewart AK, Avet-Loiseau H (2004) Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 64:1546–1558

Article  PubMed  CAS  Google Scholar 

Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, Morgan G, Van Ness B, Chesi M, Minvielle S, Neri A, Barlogie B, Kuehl WM, Liebisch P, Davies F, Chen-Kiang S, Durie BG, Carrasco R, Sezer O, Reiman T, Pilarski L, Avet-Loiseau H (2009) International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia 23:2210–2221. https://doi.org/10.1038/leu.2009.174

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hunter ZR, Xu L, Tsakmaklis N, Demos MG, Kofides A, Jimenez C, Chan GG, Chen J, Liu X, Munshi M, Gustine J, Meid K, Patterson CJ, Yang G, Dubeau T, Samur MK, Castillo JJ, Anderson KC, Munshi NC, Treon SP (2018) Insights into the genomic landscape of MYD88 wild-type Waldenstrom macroglobulinemia. Blood Adv 2:2937–2946. https://doi.org/10.1182/bloodadvances.2018022962

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jones D, Bhatia VK, Krausz T, Pinkus GS (1999) Crystal-storing histiocytosis: a disorder occurring in plasmacytic tumors expressing immunoglobulin kappa light chain. Hum Pathol 30:1441–1448

Article  PubMed  CAS